THE ROLE OF STAPHYLOCOCCUS AUREUSIN THE CLINICAL DIAGNOSIS OF DIABETIC PATIENTS

1.Alizargar J., Sharif M.R., Sharif A.: Risk factors of methicillin- resistant Staphylococcus aureus colonization in diabetic outpatients, a prospective cohort study. Int. J. Microbiol. Res.4, 147–151 (2013)Search in Google Scholar

2.Alonzo F., Torres V.J.: The bicomponent pore-forming leuco- cidins of Staphylococcus aureus. Microbiol. Mol. Biol. Rev. 78, 199–230 (2014)Search in Google Scholar

3.Badaru A., Pihoker C.: Type 2 diabetes in childhood: clinical characteristics and role of β-cell autoimmunity. Curr. Diab. Rep. 12, 75–81 (2012)10.1007/s11892-011-0247-2Search in Google Scholar

4.Burian M., Grumann D., Holtfreter S., Wolz C., Goerke C., Bröker B.M.: Expression of staphylococcal superantigens during nasal colonization is not sufficient to induce a systemic neutralizing antibody response in humans. Eur. J. Clin. Microbiol. Infect. Dis. 31, 251–256 (2012)Search in Google Scholar

5.Casqueiro J., Casqueiro J., Alves C.: Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J. Endocrinol. Metab. 16, 27–36 (2012)Search in Google Scholar

6.Cervantes-García E., García-Gonzalez R., Reyes-Torres A., Resendiz-Albor A.A., Salazar-Schettino P.M.: Staphylococcus aureus small colony variants in diabetic foot infections. Diabet. Foot Ankle, 6, 26431 (2015)10.3402/dfa.v6.26431Search in Google Scholar

7.Dai X., Zhan J., Demmy T.A., Poordad F.B., Fauceglia P.L., Zhang H., Wu L.: Monocytes play different roles in stimulating T cells in obese diabetic individuals. Int. J. Immunopathol. Pharmacol.28, 374–383 (2015)10.1177/0394632015598848Search in Google Scholar

8.De Bus L., Coessens G., Boelens J., Claeys G., Decruyenaere J., Depuydt P.: Microbial etiology and antimicrobial resistance in healthcare-associated versus community-acquired and hospital-acquired bloodstream infection in a tertiary care hospital. Diagn. Microbiol. Infect. Dis. 77, 341–345 (2013)Search in Google Scholar

9.DeFuria J., Belkina A.C., Jagannathan-Bogdan M., Snyder- Cappione J., Carr J.D., Nersesova Y.R., Markham D., Stris- sel K.J., Watkins A.A., Zhu M., Allen J., Bouchard J., Toraldo G., Jasuja R., Obin M.S., McDonnell M.E., Apovian C., Denis G.V., Nikolajczyk B.S.: B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl. Acad. Sci. USA, 110, 5133–5138 (2013)10.1073/pnas.1215840110Search in Google Scholar

10.Dumont A.L., Nygaard T.K., Watkins R.L., Smith A., Kozhaya L., Kreiswirth B.N., Shopsin B., Unutmaz D., Voyich J.M., Torres V.J.: Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 79, 814–825 (2011)Search in Google Scholar

11.Fast D.J., Schlievert P.M., Nelson R.D.: Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor Necrosis factor. J. Immunol. 140, 949–853 (1988)Search in Google Scholar

12.Fijałkowski K., Czernomysy-Furowicz G., Ferlas M.: Staphylococcus aureus versus the immune system. Post. Mikrobiol. 47, 497–501 (2008)Search in Google Scholar

13.Frasca D., Ferracci F., Diaz A., Romero M., Lechner S., Blomberg B.B.: Obesity decreases B cell responses in young and elderly individuals. Obesity (Silver Spring), 24 615–625 (2016)10.1002/oby.21383Search in Google Scholar

14.Fraser J.D., Proft T.: The bacterial superantigen and superantigen-like proteins. Immunol. Rev.225, 226–243 (2008)10.1111/j.1600-065X.2008.00681.xSearch in Google Scholar

15.Gillet Y., Etienne J. i wsp.: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet, 359, 753–759 (2002)10.1016/S0140-6736(02)07877-7Search in Google Scholar

16.Gravet, A., Colin D.A., Keller D., Girardot R., Monteil H., Prévost G.: Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett. 436, 202–208 (1998)10.1016/S0014-5793(98)01130-2Search in Google Scholar

17.Guha M., Bai W., Nadler J.L., Natarajan R.: Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem. 275, 17728–17739 (2000)Search in Google Scholar

18.Hernandez C., Cobos-Trigueros N., Feher C., Morata L., De La Calle C., Marco F., Almela M., Soriano A., Mensa J., Del Rio A., Martinez J.A.: Community-onset bacteraemia of unknown origin: clinical characteristics, epidemiology and outcome. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1973–1980 (2014)Search in Google Scholar

19.Holtfreter S., Bauer K., Thomas D., Feig C., Lorenz V., Roschack K., Friebe E., Selleng K., Lövenich S., Greve T., Greinacher A., Panzig B., Engelmann S., Lina G., Bröker B.M.: egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect. Immun.72, 4061–4071 (2004)10.1128/IAI.72.7.4061-4071.200442745815213151Search in Google Scholar

20.Huseby M.J., Kruse A.C., Digre J., Kohler P.L., Vocke J.A., Mann E.E., Bayles K.W., Bohach G.A., Schlievert P.M., Ohlen- dorf D.H., Earhart C.A.: Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proc. Natl. Acad. Sci. USA, 107, 14407–14412 (2010)10.1073/pnas.0911032107292255420660751Search in Google Scholar

21.Klein E., Smith D.L., Laxminarayan R.: Hospitalizations and deaths caused by methicillin- resistant Staphylococcus aureus, United States, 1999–2005. Emerg. Infect. Dis. 13, (2007)Search in Google Scholar

22.Klekotka R.B., Mizgała E., Król W.: The etiology of lower respiratory tract infections in people with diabetes. Pneumonol. Alergol. Pol. 83, 401–408 (2015)Search in Google Scholar

23.Kluytmans J., van Belkum A., Verbrugh H.: Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10, 505–520 (1997)10.1128/CMR.10.3.505Search in Google Scholar

24.Kulhankova K., King J., Salgado-Pabón W.: Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression. Immunol. Res. 59, 182–187 (2014)10.1007/s12026-014-8538-8Search in Google Scholar

25.Kübler A., Jaeschke R., Jankowski M.: Sepsis and septic shock. In Szczeklik A. (ed), Internal Diseases. The state of knowledge on year 2010. Practical Medicine, Kraków, s. 2200–2205 (2010)Search in Google Scholar

26.Laupland K.B., Gregson D.B., Zygun D.A., Doig C.J., Mortis G., Church D.L.: Severe bloodstream infections: a population-based assessment. Crit. Care Med. 32, 992–997 (2004)10.1097/01.CCM.0000119424.31648.1ESearch in Google Scholar

27.Lee P.K., Deringer J.R., Kreiswirth B.N., Novick R.P., Schlie- vert P.M.: Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins. Infect. Immun. 59, 879–884 (1991)Search in Google Scholar

28.Lipsky B.A., Pecoraro R.E., Chen M.S., Koepsell T.D.: Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care, 10, 483–486 (1987)10.2337/diacare.10.4.483Search in Google Scholar

29.Lipsky B.A., Tabak Y.P., Johannes R.S., Vo L., Hyde L., Weigelt J.A.: Skin and soft tissue infections in hospitalized patients with diabetes: Culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia, 53, 914–923 (2010)10.1007/s00125-010-1672-5Search in Google Scholar

30.Lydyard P.M., Whelan A., Fanger M.W.: Short lectures. Immunology, Scientific Publishing PWN SA, Warszawa, s. 97–103 (2008)Search in Google Scholar

31.Małecki R., Rosiński K., Adamiec R.: Etiological factors of infections in diabetic foot syndrome – attempt to define optimal empirical therapy. Adv. Clin. Exp. Med. 23, 39–48 (2014)Search in Google Scholar

32.McKane C.K., Marmarelis M., Mendu M.L., Moromizato T., Gibbons F.K., Christopher K.B.: Diabetes mellitus and community-acquired bloodstream infections in the critically ill. J. Crit. Care.29, 70–76 (2014)10.1016/j.jcrc.2013.08.019Search in Google Scholar

33.Miro J.M., Fowler V.G. i wsp.: Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin. Infect. Dis. 41, 507–514 (2005)Search in Google Scholar

34.Mueller E.A., Merriman J.A., Schlievert P.M.: Toxic Shock Syndrome Toxin-1, Not Alpha Toxin, Mediated Bundaberg Fatalities. Microbiology, 161, 2361–2368 (2015)10.1099/mic.0.000196Search in Google Scholar

35.Muñoz P., Hortal J., Giannella M., Barrio J.M., Rodríguez- -Créixems M., Pérez M.J., Rincón C., Bouza E.: Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J. Hosp. Infect. 68, 25–31 (2008)Search in Google Scholar

36.Naber C.K.: Staphylococcus aureus Bacteremia: Epidemiology, pathophysiology, and management strategies. Clin. Infect. Dis. 48, 231–237 (2009)Search in Google Scholar

37.Nada H.A., Gomaab N.I.M., Elakhrasa A., Wasfya R., Bakera A.: Skin colonization by superantigen-producing Staphylococcus aureus in Egyptian patients with atopic dermatitis and its relation to disease severity and serum interleukin-4 level. Int. J. Infect. Dis. 16, 29–33 (2012)Search in Google Scholar

38.Nienaber J.J., Sharma Kuinkel B.K., Clarke-Pearson M., Lamlert- thon S., Park L., Rude T.H., Barriere S., Woods C.W., Chu V.H., Marín M., Bukovski S., Garcia P., Corey G.R., Korman T., Doco- Lecompte T., Murdoch D.R., Reller L.B, Fowler V.G.: Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. J. Infect. Dis. 204, 704–713 (2011)Search in Google Scholar

39.Olokoba A.B., Obateru O.A., Olokoba L.B.: Type 2 diabetes mellitus: a review of current trends. Oman Med. J. 27, 269–273 (2012)Search in Google Scholar

40.Panton P.N., Valentine F.C.O.: Staphylococcal toxin. Lancet, 219, 506–508 (1932)10.1016/S0140-6736(01)24468-7Search in Google Scholar

41.Petrovici C.G., Dorobăt C., Bejan C., Juganariu G., Simiraş E., Filip O., Luca V., Miftode E.: Epidemiology and clinical features in diabetic patients with invasive infections treated at the Clinical Hospital of Infectious Diseases of laşi, Romania, between 2008–2010. Rev. Med. Chir. Soc. Med. Nat. Iasi.115, 1035–1041 (2011)Search in Google Scholar

42.Petrovici C.G., Leca D., Teodor A., Dorneanu O., Juganariu G., Dorobăt C., Egidia M.: Bacterial meningitis during sepsis in diabetic patient. Rev. Med. Chir. Soc. Med. Nat. Iasi.117, 901–907 (2013)Search in Google Scholar

43.Piya M.K., McTernan P.G., Kumar S.: Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J. Endocrinol. 216, T1-T15 (2013)10.1530/JOE-12-049823160966Search in Google Scholar

44.Poindexter N.J., Schlievert P.M.: Suppression of immunoglobu- lin-secreting cells from human peripheral blood by toxic-shocksyndrome toxin-1. J. Infect. Dis.153, 772–779 (1986)10.1093/infdis/153.4.7723512737Search in Google Scholar

45.Pragman A.A., Schlievert P.M.: Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. FEMS Immunol. Med. Microbiol. 42, 147–154 (2004)Search in Google Scholar

46.Price C.L., Al Hassi H.O., English N.R., Blakemore A.I., Stagg A.J., Knight S.C.: Methylglyoxal modulates immune responses: relevance to diabetes. J. Cell. Mol. Med. 14, 1806– 1815 (2010)Search in Google Scholar

47.Przyjałkowski W.: Central nervous system infections. In Szcze- klik A. (ed), Internal Diseases. The state of knowledge on year 2010, Practical Medicine, Kraków, s. 2149–2171 (2010)Search in Google Scholar

48.Rodríguez E.A., Correa M.M., Ospina S., Atehortúa S.L., Jimé- nez J.N.: Differences in epidemiological and molecular characteristics of nasal colonization with Staphylococcus aureus(MSSA-MRSA) in children from a university hospital and day care centers. Plos One, 9, e101417 (2014)10.1371/journal.pone.0101417407929824987854Search in Google Scholar

49.Roliński J., Sacha T., Immunosuppression. In Szczeklik A. (ed), Internal Diseases. The state of knowledge on year 2010, Practical Medicine, Kraków, s. 1599–1608 (2010)Search in Google Scholar

50.Salgado-Pabón W., Breshears L., Spaulding A.R., Merriman J.A., Stach C.S., Horswill A.R., Peterson M.L., Schlievert P.M.: Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury. M. bio.4, 00494–00513 (2013)10.1128/mBio.00494-13374758623963178Search in Google Scholar

51.Salgado-Pabón W., Schlievert P.M.: Models matter: the search for an effective Staphylococcus aureus vaccine. Nat. Rev. Microbiol. 12, 585–591 (2014)10.1038/nrmicro330824998740Search in Google Scholar

52.Shah B.R., Huh J.E.: Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care, 26, 510–513 (2003)10.2337/diacare.26.2.51012547890Search in Google Scholar

53.Shallcross L.J., Fragaszy E., Johnson A.M., Hayward AC.: The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 13, 43–54 (2013)Search in Google Scholar

54.Shambat M., Haggar S., Vandenesch A., Lina F., van Wamel G., Arakere W.J., Swensson G., Norrby-Teglund M.A.: Levels of alpha-toxin correlate with distinct phenotypic response profiles of blood mononuclear cells and with agr background of community-associated Staphylococcus aureus isolates. Plos One, 9, e106107 (2014)10.1371/journal.pone.0106107414839825166615Search in Google Scholar

55.Sieradzki J.: Diabetes mellitus and metabolic syndrome. In Szczeklik A. (ed), Internal Diseases. The state of knowledge on year 2010, Practical Medicine, Kraków, , s. 1243–1284 (2010)Search in Google Scholar

56.Sollid J.U., Furberg A.S., Hanssen A.M., Johannessen M.: Staphylococcus aureus: determinants of human carriage. Infect. Genet. Evol. 21, 531–41 (2014)Search in Google Scholar

57.Spaan A.N., Schiepers A., de Haas C.J., van Hooijdonk D.D., Badiou C., Contamin H., Vandenesch F., Lina G., Gerard NP., Gerard C., van Kessel K.P., Henry T., van Strijp J.A.: Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors. J. Immunol. 195, 1034–1043 (2015).10.4049/jimmunol.1500604450685326091719Search in Google Scholar

58.Spaulding A.R., Salgado-Pabón W., Kohler P.L., Horswill A.R., Leung D.Y., Schlievert P.M.: Staphylococcal and streptococcal superantigen exotoxins. Clin. Microbiol. Rev. 26, 422–447 (2013)Search in Google Scholar

59.Spaulding A.R., Satterwhite E.A., Lin Y.C., Chuang-Smith O.N., Frank K.L., Merriman J.A., Schaefers M.M., Yarwood J.M., Peterson M.L., Schlievert P.M.: Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits. Front. Cell. Infect. Microbiol.2, 18 (2012)10.3389/fcimb.2012.00018341757422919610Search in Google Scholar

60.Stoeckle M., Kaech C., Trampuz A., Zimmerli W.: The role of diabetes mellitus in patients with bloodstream infections. Swiss Med. Wkly. 138, 512–529 (2008)Search in Google Scholar

61.van Belkum A., Verkaik N.J., de Vogel C.P., Boelens H.A., Verveer J., Nouwen J.L., Verbrugh H.A., Wertheim H.F.L.: Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 15, 199,1820–1826 (2009)Search in Google Scholar

62.Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.E., Etienne J.: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9, 978–984 (2003)Search in Google Scholar

63.Voyich J.M., Braughton K.R., Sturdevant D.E., Whitney A.R., Saïd-Salim B., Porcella S.F., Long R.D., Dorward D.W., Gardner D.J., Kreiswirth B.N., Musser JM., DeLeo F.R.: Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175, 3907–3919 (2005)10.4049/jimmunol.175.6.390716148137Search in Google Scholar

64.Vu B.G., Gourronc F.A., Bernlohr D.A., Schlievert P.M., Klingel- hutz A.J.: Staphylococcal superantigens stimulate immortalized human adipocytes to produce chemokines. Plos One,8, e77988 (2013)10.1371/journal.pone.0077988381349524205055Search in Google Scholar

65.Vu B.G., Stach C.S., Kulhankova K., Salgado-Pabón W., Klingel- hutz A.J, Schlievert PM.: Chronic superantigen exposure induces systemic inflammation, elevated bloodstream endotoxin, and abnormal glucose tolerance in rabbits: possible role in diabetes. M. Bio. 24, e02554 (2015)10.1128/mBio.02554-14435800725714716Search in Google Scholar

66.Vu B.G., Stach C.S., Salgado-Pabón W., Diekema D.J., Gardner S.E., Schlievert P.M.: Superantigens of Staphylococcus aureusfrom patients with diabetic foot ulcers. J. Infect. Dis. 210, 1920– 1927 (2014)Search in Google Scholar

67.Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., Nouwen J.L.: The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5, 751–762 (2005)Search in Google Scholar

68.Xiong Y.Q., Willard J., Yeaman M.R., Cheung A.L., Bayer A.S.: Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J. Infect. Dis.194, 1267–1275 (2006)10.1086/50821017041853Search in Google Scholar

69.Yazdanpanah L., Nasiri M., Adarvishi S.: Literature review on the management of diabetic foot ulcer. World J. Diabetes. 15, 37–53 (2015)Search in Google Scholar

70.Zhai X., Qian G., Wang Y., Chen X., Lu J., Zhang Y., Huang Q., Wang Q.: Elevated B Cell Activation is Associated with Type 2 Diabetes Development in Obese Subjects. Cell. Physiol. Biochem. 38, 1257–1266 (2016)Search in Google Scholar